AliveCor

AliveCor KardiaMobile 6L

Name: AliveCor KardiaMobile 6L
Brand: AliveCor
Price: 1250.00 MYR
Availability: InStock

RM1,250.00 MYR

~~RM1,200.00 MYR~~ RM1,250.00 MYR

Sale Sold out

Product variants

Quantity

Modes: 1-lead EKG & 6-lead EKG
Detects AFib, Bradycardia, Tachycardia & Normal heart rhythm
6-lead ECG gives your doctor more detailed heart information
Provides doctors visibility into certain arrhythmias that are leading indicators of cardiovascular disease

6 times the data.

From the comfort of home.

Never before has more heart health information been available at your fingertips. Share detailed 6-lead ECGs with your doctor for a better view of your heart. And help your doctor provide you with even better care.

1 year warranty (T&C applied)

View full details

OUR FEATURED PRODUCT

Introducing KardiaMobile 6L

NEW TECHNOLOGY BEHIND

Overview

Two sensors on top.

And now, a third on the bottom.

KardiaMobile 6L has two electrodes on the top for your fingers, and one on the bottom to contact the skin of your left leg. KardiaMobile 6L delivers EKG leads I, II, III, aVL, aVR, and aVF. All without messy gels and wires.

WHY KARDIA

Manage Your Condition

Instantly detect atrial fibrillation (AFib) and normal sinus rhythm with a 30 seconds ECG

Trusted

FDA-cleared, medical-grade ECG recordings

Easy To Use

Just put your fingers on the sensors---no wires, patches or gels required

Portable

Check in with your heart on the go. Just slip it in your pocket and take it with you anytime, anywhere

Personalised ECG tracker

Check in with your heart on the go. Just slip it in your pocket and take it with you anytime, anywhere

YOUR HEART HEALTH AT YOUR FINGERTIPS

Our Features

"A proven, reliable mobile ECG device with a solid algorithm for rhythm diagnosis." ---------The Sceptical Cardiologist

1-lead ECG / 6-lead ECG
Detects AFib, Bradycardia, Tachycardia & Normal Heart Rhythm
6-lead ECG (I, II, III, aVL, aVR, and aVF) gives your doctor more detailed heart information.
Provides visibility to doctors into leading indicators of cardiovascular disease